boron neutron capture therapy

Borofalan-10B (L-4-Boronophenylalanine) echibits antineoplastic effects. Borofalan can be used in studies on recurrent or locally advanced head and neck cancer.

Boronophenylalanine B-10 (BPA) is a boron delivery agent used in boron neutron capture therapy (BNCT) for the treatment of metastatic melanoma and other tumors.

Borofalan (also known as SPM 011) is an adjuvant compound used in boron neutron capture therapy (BNCT) for cancer treatment. BNCT leverages the high neutron capture cross-section of boron-containing compounds (10 B) and facilitates the 10 B(n,α) 7 Li neutron capture and nuclear fission reaction. With the use of borofalan (10B)-containing C-BENS, BNCT has demonstrated effective therapeutic potential in patients with R-SCC or R/LA-nSCC of the head and neck. Note: We offer the non-labeled version of Borofalan.

4-Borono-L-phenylalanine has antitumor activity and may be used in clinical trials of boron neutron capture therapy for the treatment of melanoma and glioblastoma multiforme.

Borocaptate-10B12 (BSH-10B12) sodium is a boron-10 (10B) labeled compound known as Borocaptate sodium. This boron-containing substance serves as a therapeutic agent in boron neutron capture therapy (BNCT) and exhibits anticancer activity.